Back to Rankings

FBRX

Forte BiosciencesD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
FBRX vs peer average
40/100
FBRX vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 3 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ZURA is the first available peer comparator.

Autoimmune-focused clinical-stage biotech and the closest peer in the packet for readout-driven valuation, though the pipeline and mechanisms differ.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerZURAZura Bio
FBRX
Forte Biosciences
ZURA
Zura Bio
Grade
D
C
Momentum
100
83
Value
41
41
Sentiment
0
40
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs ZURA

FBRX / ZURA
Grade Position
Below peers
FBRX vs. peer average (D vs. C)
40/100
Momentum
100
FBRX
Value
41
FBRX
Sentiment
0
ZURA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FBRX
1
ZURA
ZURA
C
60/100
-1
2
FULC
FULC
F
20/100
+1
3
ASMB
ASMB
F
20/100
+1
4
CRON
Cronos Group Inc Common
D
40/100
Even
5
ANRO
Alto Neuroscience Inc Common
C
60/100
-1
ZURA is the first peer returned for this comparison set.